跳至主要内容
临床试验/JPRN-UMIN000002901
JPRN-UMIN000002901已完成3 期

Prophylactic efficacy of Proton Pump Inhibitor on Recurrence of Peptic Ulcer in Patients continuously treated with Low-dose Aspirin-Randomized, Multi-center, single-blinded, parallel-group, comparative study- - Prophylactic efficacy of Proton Pump Inhibitor on Recurrence of Peptic Ulcer in Patients continuously treated with Low-dose Aspirin (CARE Study)

CARE Study Group0 个研究点目标入组 285 人开始时间: 2009年12月15日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
285

研究概览

简要总结

Rabeprazole is superior for reducing the risk of recurrence of peptic ulcer, esophagitis and gastrointestinal symptoms in long-term LDA users with a history of peptic ulcer.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) patients with ischemic heart failure, which are acute phase, unstable condition or under 6 months after stent-instillation, 2) patients with brain vascular disease, which are acute phase, unstable condition or under 3 months after the first attack, 3) patients who are uncontrolled and complicated disease, for example thrombocytopenia, and unsuitable for this study as judged by investigator, 4) patients who are uncontrolled renal or liver dysfunction and unsuitable for this study as judged by investigator, 5) patients who are treated with steroid hormones, 6) patients who are women of, pregnant and lactating and childbearing, 7) Patients who are alcoholism, 8) patients who show the hypersensitivity for test drugs, 9) patients who are enrolled in another clinical study, 10) patients who are judged as unsuitable by investigator

研究者

发起方
CARE Study Group

相似试验